---
nav_exclude: true
title: "Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices --- United States, 2019"
source_url: "https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=403273"
source_layer: us_cdc_mmwr
category: surveillance_summary
date: 2020-01-23
confidence: 高
mmwr_volume: ""
mmwr_issue: ""
---

## 摘要

New Advisory Committee on Immunization Practices recommendations allow more flexibility for use of either tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) or tetanus and diphtheria toxoids (Td) vaccines in three scenarios where only Td had been previously recommended, most notably for tetanus booster doses recommended every 10 years for all adults.

## 詳細內容

New Advisory Committee on Immunization Practices recommendations allow more flexibility for use of either tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) or tetanus and diphtheria toxoids (Td) vaccines in three scenarios where only Td had been previously recommended, most notably for tetanus booster doses recommended every 10 years for all adults.

## 關鍵發現

(需要透過 WebFetch 補充或人工審核來提取關鍵發現)

---
*萃取時間: 2026-02-05T15:16:16Z*
*資料來源: CDC MMWR*
